Experimental data reported by studies performed using different models of kidney injury, such as chronic glomerulonephritis [37,38,39,40], diabetic nephropathy [41,42], Lupus Nephritis [43], crystalline nephropathy [44,45,46,47] and hypertensive nephropathy [48,49,50], have shown that NLRP3 inflammasome activation participates in the underlying pathogenetic events involved in the onset and progression of kidney damage, regardless of the aetiology of kidney disease. The gene discussed is NLRP3; the disease is kidney disorder.